Hyperammonemic encephalopathy: A rare presentation of fibrolamellar hepatocellular carcinoma

American Journal of the Medical Sciences

Volumn 338, Issue 6, 2009, Pages 522-524

  Sethi, Saurabh ^a   Tageja, Nishant ^a   Singh, Jatinder ^b   Arabi, Haitham ^a   Dave, Maneesh ^a   Badheka, Apurva ^a   Revankar, Sanjay ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Fibrolamellar carcinoma; Hep Par 1; Hyperammonemic encephalopathy; Sorafenib

Indexed keywords

AMMONIA; SORAFENIB;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG TREATMENT FAILURE; FIBROLAMELLAR CARCINOMA; HUMAN; HUMAN TISSUE; HYPERAMMONEMIA; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; METASTASIS; URINE INCONTINENCE; ADOLESCENT; LIVER TUMOR; PATHOLOGY; TOXICITY AND INTOXICATION;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; HUMANS; HYPERAMMONEMIA; LIVER NEOPLASMS; MALE; NEUROTOXICITY SYNDROMES;

EID: 73949145154     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181bccfb4     Document Type: Article

References (9)

1. Edmonson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. Arch Dis Child 1956;1:168-186
2. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997;26:877-883
3. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-379
4. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-1054
5. Levy LJ, Swinburne LM, Boulton RP, et al. Primary hepatocellular carcinoma presenting as fulminant hepatic failure in a young woman. Postgrad Med J 1986;62:1135-1137
6. Eras P, Sherlock P. Hepatic coma secondary to metastatic liver disease. Am Intern Med 1971;74:581-583
7. Hamilton SR, Aaltonen LA, editors. Tumors of the liver and intrahepatic bile ducts. In: Pathology and genetics of the digestive system. Lyon: IARC Press; 2000. p. 159-172
8. Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 2005;18: 1417-1423
9. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390